#Neutrophils are the body’s first responders and co-ordinators of immune defense. But do they play a more malignant role in #cancer progression? Join our upcoming webinar to explore how distinct immature neutrophil subsets fuel tumor growth and metastasis. buff.ly/DDC3saU

September is Polycystic Ovary Syndrome (#PCOS) Awareness Month. #GemPharmatech advances PCOS research by providing a comprehensive suite of #preclinical solutions backed by validated models that recapitulate the disease’s biological complexity. Learn more: buff.ly/6PydytW

A huge thank you to everyone who joined our seminar at Shonan Health Innovation Park (Global) this week! Our goal is to help scientists access advanced preclinical platforms that de-risk translational research and bring new treatments to patients faster. Learn more: buff.ly/DzjGv4k #GemPharmatech

Immune checkpoint inhibitors targeting PD-1 have revolutionized #cancertreatment. Join our upcoming #webinar as we explore how researchers can navigate the complexities of the post-PD1 landscape through optimized strategies and validated in vivo platforms: buff.ly/jdmqSiy

#GemPharmatech is thrilled to announce our participation in the 84th Annual Meeting of the Japanese #Cancer Association! Don’t miss our oral and  poster presentations by Dr. Shiying Guo. Let's create some amazing memories in Kanazawa! #JapaneseCancerAssociation #JCA25 #JCA

You're invited! #GemPharmatech is hosting an exclusive seminar at BioInnovation Institute on October 21, 2025. With only 30 spots available, this is your chance to be at the forefront of #preclinical innovation. We'll provide free lunch and exquisite souvenirs. 👉 buff.ly/23Pv48V

We had an amazing time at the NCAB 2025 Seminar! Thank you to the organizers for organizing such a great and collaborative event. Reach out to Keiji Furuuchi, PhD if you didn’t have a chance to speak with us. #GemPharmatech #NCABAALAS #LifeSciences #Biotech #Networking #Research

Unlocking the next generation of #biologics requires powerful #preclinical tools. Join us Sept. 30 through Oct. 2 as GemPharmatech exhibits at Festival of Biologics in Basel, Switzerland and see for yourself how we're accelerating discovery and development! #FOB2025

It's the Final Day of #HDC25! Stop by our table to discover how our robust #metabolic disease models can power your research. Meet Eric Wang and Jianming Xu to learn more about how GemPharmatech can help accelerate your projects! #HelmholtzDiabetes2025 #MetabolicResearch #Biotech

Time is running out! Join #GemPharmatech's upcoming webinar: "Overcoming Challenges in the Post-PD-1 Era of Cancer Immunotherapy " Register Now: buff.ly/5mCyjHV #CancerResearch #Immunotherapy #Oncology #Immuno

The complexity of Diabetic Nephropathy (DN), driven by both chronic hyperglycemia and systemic hypertension, has long hindered therapeutic development. GemPharmatech has developed two progressive diabetic kidney disease #mousemodels to support DN research: buff.ly/oMa5ztG

#GemPharmatech is proud to sponsor the inaugural T-Cell Engager for #Autoimmune Disease Summit this October! Join us during the summit to connect with our experts and discuss your specific #research needs. Don't miss our presentation on Wednesday, October 15 at 2:30 p.m. #TCE

Attending @SABPA’s 23rd San Diego Biopharma Conference? Join #GemPharmatech on October 4 for a day of exploring the latest breakthroughs, innovations, and collaboration opportunities shaping the future of #biopharma! Let's drive innovation together in San Diego! #SDBioPharma

Our team is in Kanazawa, Japan, for the 84th Annual Meeting of the Japanese Cancer Association (#JCA84). Connect with us today at our poster presentation session: “Modeling ADC Resistance Using Induced Preclinical Enhertu Resistant Models” Time:  15:30 to 16:15 #JCA2025

GemPharmatech is excited to announce our participation in Bio Japan 2025!  Log in to the Bio Japan Partnering System to schedule a meeting with us in advance! 📅 Date: October 8 – 10, 2025 📍 Venue: PACIFICO Yokohama 🪑 Booth #: 𝗕-𝟵𝟯 #BioJapan2025 #BioJapan

In a recent study, researchers achieved efficient base editing of human hematopoietic stem cells using LNP-mRNA delivery, without pre-conditioning or transplantation. At the heart of this breakthrough is our next-generation #NCG portfolio. Read more: buff.ly/xbqh10Y

We are thrilled to be in attendance on the second day of the #FestivalofBiologics 2025! Stop by Booth 266 today and join us to learn about our end-to-end preclinical solutions that reduce timelines and de-risk development for #antibody therapies, cell and gene therapies. #FoB25

Hypertrophic cardiomyopathy (#HCM) is the most common hereditary #heartdisease, yet current treatment options remain limited, often alleviating symptoms without addressing the root cause. Learn how our models can empower your HCM drug discovery program: buff.ly/DqSnbtG

In our upcoming webinar, Dr. Yan Li, Director of Nanjing University’s Model Animal Research Center, will reveal how specific neutrophil subsets drive tumor growth and metastasis, and how targeted interventions may restore anti-tumor immunity. Register Now: buff.ly/1ioVNMm

We're heading to Gothenburg for #NordicLifeScienceDays 2025! Join us at Booth B01:15 as they showcase the cutting-edge mouse models and latest R&D capabilities that keep us at the forefront of the industry. Find us on partneringONE to schedule a one-to-one meeting! #NLSDays2025